Akathisia. Other specified extrapyramidal and movement disorders
Conditions
Interventions
Intervention 1: Intervention group: Patients with a Slow Infusion of Metoclopramide 20 mg of Plasil in 20 Minutes will be prescribed. Intervention 2: Intervention group: Patients will be given Infusio
Treatment - Drugs
Intervention group: Patients with a Slow Infusion of Metoclopramide 20 mg of Plasil in 20 Minutes will be prescribed.
Intervention group: Patients will be given Infusion with Bolus Placebo 20 mg of Plasil within 2 Minutes.
Control group: Patients will be given Infusion Bolus Metoclopramide 20 mg of Plasil within 2 Minutes.
Control group: Patients will be given a Placebo Slow Infusion of 20 mg Plasil in 20 Minutes.
Sponsors
Sari University of Medical Sciences
Eligibility
Sex/Gender
All
Age
19 Years to 70 Years
Inclusion criteria
Inclusion criteria: Patients with Cancer over 19 Years of Age will be admitted to the Emergency Department at Imam Hospital for any Reason, Indicating Metoclopramide Infusion.
Exclusion criteria
Exclusion criteria: Patients who are not able to give informed Consent Patients who have Metoclopramide before taking Metoclopramide have Actagenia Patients with Parkinson's Disease and Restless Legs Syndrome Patients with Refractory Nausea due to the Underlying problem, such as brain Hemorrhage Patients who received Dopamine Antagonists over the past 24 Hours
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Akathisia. Timepoint: The primary and secondary consequences will be measured at intervals of 0, 30, 60 and 120 minutes after Metoclopramide administration. Method of measurement: The Akathisia measure will use the Henry Akathisia Rating Scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Nausea. Timepoint: The Primary and Secondary Consequences will be measured at Intervals of 0, 30, 60 and 120 minutes after Metoclopramide Administration. Method of measurement: It will be measured using the VAS scale.;Drowsiness. Timepoint: The Primary and Secondary Consequences will be measured at Intervals of 0, 30, 60 and 120 minutes after Metoclopramide Administration. Method of measurement: The Ramsay Sedation Scale will be used to Measure Drowsiness.;The Patient's Vital Signs include pulse and Blood Pressure, Allergic Reaction. Timepoint: The Primary and Secondary Consequences will be measured at Intervals of 0, 30, 60 and 120 minutes after Metoclopramide Administration. Method of measurement: Examination. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactEnsieh Taghizadeh
Sari University of Medical Sciences
Outcome results
None listed